KMC Speciality Hospitals (India) Ltd
₹ 118
3.69%
10 Jun
3:31 p.m.
About
Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.
Key Points
- Market Cap ₹ 1,925 Cr.
- Current Price ₹ 118
- High / Low ₹ 125 / 62.5
- Stock P/E 41.1
- Book Value ₹ 12.9
- Dividend Yield 0.00 %
- ROCE 26.0 %
- ROE 24.9 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 29.6% CAGR over last 5 years
- Company's median sales growth is 22.9% of last 10 years
Cons
- Stock is trading at 9.28 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36 | 43 | 55 | 71 | 82 | 96 | 103 | 136 | 156 | 177 | 232 | 306 | |
| 31 | 35 | 42 | 56 | 66 | 75 | 79 | 99 | 114 | 129 | 174 | 218 | |
| Operating Profit | 6 | 8 | 12 | 14 | 16 | 21 | 23 | 37 | 42 | 48 | 57 | 88 |
| OPM % | 16% | 19% | 23% | 20% | 20% | 22% | 23% | 28% | 27% | 27% | 25% | 29% |
| 0 | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 3 | 4 | 3 | 5 | |
| Interest | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 10 | 8 |
| Depreciation | 4 | 3 | 3 | 4 | 4 | 5 | 6 | 7 | 8 | 9 | 19 | 22 |
| Profit before tax | 0 | 4 | 8 | 10 | 12 | 17 | 18 | 32 | 36 | 41 | 32 | 63 |
| Tax % | 0% | 21% | 33% | 32% | 30% | 30% | 29% | 26% | 26% | 25% | 32% | 26% |
| 0 | 3 | 5 | 7 | 9 | 12 | 13 | 24 | 27 | 30 | 21 | 47 | |
| EPS in Rs | 0.01 | 0.20 | 0.33 | 0.41 | 0.53 | 0.72 | 0.78 | 1.46 | 1.64 | 1.86 | 1.31 | 2.87 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 24% |
| 3 Years: | 25% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 30% |
| 3 Years: | 20% |
| TTM: | 118% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 24% |
| 3 Years: | 21% |
| 1 Year: | 67% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 23% |
| 3 Years: | 21% |
| Last Year: | 25% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | -6 | -3 | 8 | 14 | 23 | 34 | 47 | 70 | 97 | 127 | 148 | 194 |
| 14 | 10 | 6 | 15 | 10 | 9 | 29 | 29 | 50 | 82 | 89 | 84 | |
| 7 | 6 | 8 | 8 | 10 | 11 | 13 | 13 | 18 | 38 | 32 | 38 | |
| Total Liabilities | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 | 332 |
| 25 | 23 | 24 | 37 | 36 | 39 | 74 | 75 | 84 | 206 | 248 | 248 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 6 | 34 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 6 | 7 | 14 | 16 | 24 | 31 | 29 | 48 | 63 | 57 | 38 | 84 | |
| Total Assets | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 | 332 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 | 6 | 10 | 12 | 16 | 11 | 26 | 29 | 32 | 38 | 58 | 79 | |
| -1 | -1 | -4 | -19 | -9 | -8 | -43 | -29 | -48 | -56 | -51 | -17 | |
| -5 | -5 | -5 | 6 | -5 | -4 | 18 | -1 | 16 | 20 | -2 | -21 | |
| Net Cash Flow | -0 | -0 | 1 | -1 | 1 | -1 | 1 | -0 | 0 | 3 | 4 | 41 |
| Free Cash Flow | 5 | 5 | 6 | -3 | 13 | 7 | -15 | 16 | -12 | -37 | -6 | 63 |
| CFO/OP | 112% | 91% | 94% | 100% | 113% | 66% | 120% | 102% | 100% | 101% | 112% | 100% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12 | 13 | 12 | 13 | 8 | 8 | 9 | 10 | 10 | 9 | 9 | 9 |
| Inventory Days | 42 | 32 | 28 | 24 | 29 | 59 | 39 | 33 | 36 | 31 | 38 | 31 |
| Days Payable | 169 | 158 | 134 | 143 | 161 | 115 | 117 | 96 | 102 | 80 | 153 | 82 |
| Cash Conversion Cycle | -115 | -112 | -94 | -107 | -125 | -48 | -68 | -53 | -56 | -40 | -105 | -42 |
| Working Capital Days | -70 | -60 | -46 | -37 | -28 | -18 | -15 | -27 | -22 | -73 | -22 | -19 |
| ROCE % | 8% | 24% | 35% | 29% | 29% | 33% | 25% | 32% | 27% | 22% | 17% | 26% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| ALOS (Average Length of Stay) Days |
|
|||||||
| Blended ARPOB (Average Revenue Per Occupied Bed) INR |
||||||||
| Average Occupancy Rate Percentage |
||||||||
| Average Occupied Beds Number |
||||||||
| Census Beds Number |
||||||||
| In-Patient Volumes Number |
||||||||
| Out-Patient Volumes Number |
||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Investor Presentation
5 Jun - Investor Presentation for the quarter and year ended 31st March, 2026
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
29 May - Filed FY26 secretarial compliance report; prior independent director delay was rectified.
-
Intimation Under Regulation 30 Of SEBI (LODR), 2015
29 May - Board approved 1-acre land purchase in Tiruchirapalli for Rs 62.50 crore to enable 300-bed expansion.
-
Announcement under Regulation 30 (LODR)-Change in Management
29 May - Board approved Grant Thornton Bharat LLP as internal auditor for FY 2026-27 on 29 May 2026.
-
Standalone Audited Financial Results For The FY 2025-2026
29 May - Board approved FY26 audited results; auditors gave unmodified opinion.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Jun 2026TranscriptAI SummaryPPT
-
Mar 2026TranscriptAI SummaryPPT
-
Nov 2025TranscriptAI SummaryPPT
-
Sep 2025TranscriptAI SummaryPPT
-
Jun 2025TranscriptAI SummaryPPT
-
Mar 2025TranscriptAI SummaryPPT
-
Dec 2024TranscriptAI SummaryPPT
-
Aug 2024TranscriptAI SummaryPPT
-
Jun 2024TranscriptAI SummaryPPT
-
Mar 2024TranscriptAI SummaryPPT
Part of Kauvery Group Hospitals:[1][2]
The company is a super-specialty hospital based in Trichy, belonging to the Kauvery Hospitals group. The group has 2250+ beds of multispecialty hospital chains at 12 locations, providing facilities for 1 lakh per year of IP patients and 10 lakhs per year of OP patients. The group is doing 600+ transplants, 1000+ Joint Replacements, and 1 lakh + Kidney procedures per year.